Parkinson’s Patients at ‘Significantly’ Lower Risk of Colorectal Cancer
People with Parkinson’s disease are significantly less likely than those without the neurodegenerative disorder to develop colorectal cancer,…
Articles by Marisa Wexler, MS
Study: Nearly 40% of Patients Have Minor Hallucinations
Nearly four of every 10 patients with Parkinson’s disease experience minor hallucinations, a new study from China estimates. Results…
Study Exploring Why Alpha-synuclein Hurts Some Cells But Not Others
A new research project seeks to better characterize the structural properties of alpha-synuclein, which researchers hope will lead to a…
Epilepsy Therapy Zonisamide Found to Reduce Parkinson’s ‘Off’ Time
Treatment with zonisamide — an approved epilepsy medication — can reduce “off” time without worsening treatment side effects in…
GCase Enzyme Activity Not Linked to Parkinson’s Risk, Severity
The activity of the enzyme glucocerebrosidase, called GCase, is not tied to the risk of developing Parkinson’s, nor…
Oral ANVS401 Improves Patients’ Motor Skills in Phase 2 Trial
Once-a-day treatment with oral ANVS401 was found to significantly improve motor skills among Parkinson’s disease patients in a Phase 2a clinical…
SBT-272, Supporting Mitochondria, Eases Disease Symptoms in Mice
Treatment with an investigational medicine called SBT-272 markedly eased signs of Parkinson’s disease in a mouse model, according…
Blocking 2 Proteins Might Stop Spread of Alpha-synuclein in Brain
The spread of alpha-synuclein aggregates in the brain is dependent on a protein receptor called TLR2, and also a transcription…
ParkinSense Startup Advancing New Motor Symptom Monitoring System
ParkinSense, an upcoming startup out of the University of Toronto, has secured funding to advance a new monitoring system that’s…
Changes in Oil on Skin’s Surface May Help to Diagnose Parkinson’s
Changes in the genetic material of the sebum — the “oil” on the skin’s surface — are evident in people…